Human coagulation factor VIII(Biotest Pharma Gmbh)

人凝血因子VIII（Biotest Pharma Gmbh）

Report date: 2024/08/30 09:58:17

Base Information

Drug NameHuman coagulation factor VIII(Biotest Pharma Gmbh)

Drug Alias NameDeimmunised Haemophilia A Therapeutic(Biotest Pharma Gmbh)Deimmunised FVIII(Biotest Pharma Gmbh)Haemophilia A Therapeutic Reduced Immunogenicity(Biotest Pharma Gmbh)HAT RI(Biotest Pharma Gmbh)Haemoctin SDH

ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEU

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiotest Pharma Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesBiotest Pharma Gmbh

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeB02BD02